Stockscreener 앱 받기
13.76
0.35%
-0.035
전일 마감가:
$13.79
열려 있는:
$13.74
하루 거래량:
502.14K
Relative Volume:
0.27
시가총액:
$1.63B
수익:
$260.81M
순이익/손실:
$20.48M
주가수익비율:
105.81
EPS:
0.13
순현금흐름:
$22.67M
1주 성능:
-1.92%
1개월 성능:
+10.37%
6개월 성능:
+25.26%
1년 성능:
+8.71%
1일 변동 폭
$13.65
$13.84
1주일 범위
$13.65
$14.63
52주 변동 폭
$9.74
$14.63
다이나백스 테크놀로지스 Stock (DVAX) Company Profile
명칭
Dynavax Technologies Corp
전화
(510) 848-5100
주소
2100 POWELL STREET, EMERYVILLE, CA
DVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
13.76 | 1.63B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
161.37 | 71.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.87 | 47.16B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.31 | 46.33B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.13 | 18.69B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.21 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
다이나백스 테크놀로지스 Stock (DVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-02-01 | 개시 | Goldman | Neutral |
| 2022-09-27 | 개시 | JMP Securities | Mkt Outperform |
| 2022-01-06 | 재개 | Goldman | Buy |
| 2021-08-06 | 개시 | Goldman | Buy |
| 2020-08-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-15 | 개시 | Evercore ISI | Outperform |
| 2019-10-18 | 개시 | H.C. Wainwright | Buy |
| 2019-07-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-05-10 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-03-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-09-25 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-07-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-07-31 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 개시 | RBC Capital Mkts | Outperform |
| 2013-11-25 | 업그레이드 | MLV & Co | Hold → Buy |
| 2013-02-25 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2012-11-16 | 재확인 | MLV & Co | Buy |
모두보기
다이나백스 테크놀로지스 주식(DVAX)의 최신 뉴스
Dynavax at Barclays Healthcare: Strategic Growth and Market Expansion - Investing.com
Dynavax technologies’ president & COO David Novack sells $471,473 in stock - Investing.com Canada
Dynavax Activist Investor Deep Track Capital Sends Letter to Company Board, Urging Director, Strategy Changes - Marketscreener.com
Deep Track Capital pushes for board changes at Dynavax By Investing.com - Investing.com Canada
Dynavax Turns Heads As HEPLISAV-B Shows Steady Growth In The Expanding Hepatitis B Vaccine Market - RTTNews
Deep Track Capital pushes for board changes at Dynavax - Investing.com
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - StockTitan
Dynavax Technologies Corp. to Host Earnings Call - ACCESS Newswire
Dynavax at TD Cowen Conference: Strategic Growth and Future Plans - Investing.com
Dynavax Signs Debt Refinancing Deals, Plans $8 Million Stock Buyback -March 06, 2025 at 07:54 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing -March 06, 2025 at 07:28 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing, Common Stock Share Repurchase - Nasdaq
Dynavax stock hits 52-week high at $14.05 amid robust growth - Investing.com
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Dynavax to Participate in Upcoming Investor Conferences - Yahoo Finance
Dynavax Technologies (NASDAQ:DVAX) Upgraded to Buy at StockNews.com - Defense World
Dynavax’s SWOT analysis: hepatitis B vaccine maker’s stock poised for growth - Investing.com
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet - Yahoo Finance
HC Wainwright Has Optimistic Outlook of DVAX FY2026 Earnings - Defense World
New York State Teachers Retirement System Decreases Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax Technologies (NASDAQ:DVAX) Hits New 12-Month High – Should You Buy? - Defense World
Dynavax Technologies (NASDAQ:DVAX) Earns Buy Rating from HC Wainwright - Defense World
Dynavax Technologies Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) - Benzinga
DVAX stock touches 52-week high at $13.9 amid robust performance By Investing.com - Investing.com South Africa
DVAX stock touches 52-week high at $13.9 amid robust performance - Investing.com
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Dynavax stock with $31 target - Investing.com
JMP raises Dynavax stock target to $33, maintains rating - Investing.com
Dynavax Technologies: Q4 Earnings Snapshot - CTPost
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript - AOL
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates - MSN
Earnings call transcript: Dynavax Q4 2024 shows EPS beat, revenue miss - Investing.com
High Growth Tech Stocks To Watch In February 2025 - Yahoo Finance
Dynavax Technologies climbs as investor begins proxy fight (update) - MSN
Dynavax under fire as investor targets vaccine maker’s board - The Business Journals
Dynavax Technologies (DVAX) Projected to Post Earnings on Thursday - Defense World
Palumbo Wealth Management LLC Invests $275,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors By Reuters - Investing.com
Dynavax Technologies Reiterates Board Change Already Underway -February 19, 2025 at 05:53 pm EST - Marketscreener.com
Dynavax defends strategy amid board nomination dispute - Investing.com
Deep Track Capital Nominates Four Candidates For Election To Dynavax Technologies' Board At 2025 Annual Meeting - Marketscreener.com
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors -February 19, 2025 at 08:00 am EST - Marketscreener.com
Life Sciences Investor Deep Track Launches Proxy Fight… -February 19, 2025 at 08:00 am EST - Marketscreener.com
Exclusive-Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Marketscreener.com
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Yahoo Finance
다이나백스 테크놀로지스 (DVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.00%
1.51%
자본화:
|
볼륨(24시간):